Showing 1 - 8 results of 8 for search 'Paula Vainio', query time: 0.03s Refine Results
  1. 1
    Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy

    Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy by Kalle E. Mattila, Paula Vainio, Panu M. Jaakkola

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Tumor‐to‐tumor metastasis to Warthin tumor presenting as an initial sign of breast carcinoma: A case report

    Tumor‐to‐tumor metastasis to Warthin tumor presenting as an initial sign of breast carcinoma: A case report by Iisa Mansikka, Ilpo Kinnunen, Jussi Hirvonen, Paula Vainio, Jarno Velhonoja

    Published 2023-01-01
    Get full text
    Article
  3. 3
    High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.

    High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer. by Paula Vainio, John-Patrick Mpindi, Pekka Kohonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin

    Published 2012-01-01
    Get full text
    Article
  4. 4
    External validation of a deep learning-based algorithm for detection of tall cells in papillary thyroid carcinoma: A multicenter study

    External validation of a deep learning-based algorithm for detection of tall cells in papillary thyroid carcinoma: A multicenter study by Sebastian Stenman, Sylvain Bétrisey, Paula Vainio, Jutta Huvila, Mikael Lundin, Nina Linder, Anja Schmitt, Aurel Perren, Matthias S. Dettmer, Caj Haglund, Johanna Arola, Johan Lundin

    Published 2024-12-01
    Get full text
    Article
  5. 5
    Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma

    Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma by Lassi Luomala, Kalle Mattila, Paula Vainio, Harry Nisén, Teijo Pellinen, Jouni Lohi, Teemu D. Laajala, Petrus Järvinen, Anna‐Riina Koskenniemi, Panu Jaakkola, Tuomas Mirtti

    Published 2024-02-01
    Get full text
    Article
  6. 6
    A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma

    A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma by Kalle E. Mattila, Teemu D. Laajala, Sara V. Tornberg, Tuomas P. Kilpeläinen, Paula Vainio, Otto Ettala, Peter J. Boström, Harry Nisen, Laura L. Elo, Panu M. Jaakkola

    Published 2021-04-01
    Get full text
    Article
  7. 7
    Correction: GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets.

    Correction: GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets. by John Patrick Mpindi, Henri Sara, Saija Haapa-Paananen, Sami Kilpinen, Tommi Pisto, Elmar Bucher, Kalle Ojala, Kristiina Iljin, Paula Vainio, Mari Björkman, Santosh Gupta, Pekka Kohonen, Matthias Nees, Olli Kallioniemi

    Published 2011-01-01
    Get full text
    Article
  8. 8
    GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets.

    GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets. by John Patrick Mpindi, Henri Sara, Saija Haapa-Paananen, Sami Kilpinen, Tommi Pisto, Elmar Bucher, Kalle Ojala, Kristiina Iljin, Paula Vainio, Mari Björkman, Santosh Gupta, Pekka Kohonen, Matthias Nees, Olli Kallioniemi

    Published 2011-01-01
    Get full text
    Article

Search Tools: